genomel logo
   
 
SNB study group  
Homepage menu
  A prospective cohort study investigating the determinants of survival in Stage III melanoma patients.
  BackgroundThe Team
  Study Pathway
  Requirements for Collaborators
  Inclusion Criteria
  Login
  Back to GenoMEL
   
 

This is a brief description of what is required from participating centres.

bullet 1. Collaborators must send an email to info@snb.org expressing their interest in taking part.
bullet 2. Researchers from collaborating centres can then register themselves as users on this website
bullet 3. Found an eligible patient? Then generate study number and print off required documents.
bullet 4. Consent patient.
bullet 5. Complete questionnaire A to retain. Ask patient to complete questionnaire B for posting to Leeds at 6-month intervals.
bullet 6. Collect 10mls of blood (plain tube) for serum to be frozen and mailed to Rotterdam in batches at 6-month intervals.
bullet 7. Take 20ml (EDTA tube) blood sample (DNA). Freeze and post to Leiden in batches at 6-month intervals.
bullet 8. Complete the clinical & pathological details via the online database.
bullet 9. Obtain pathology blocks & slides for review and postage to Leeds.

bullet 10. Administer annual follow-up questionnaire F by telephone.


bullet 11. Complete relapse data online annually unless the patient is part of adjuvant EORTC trials.

 
 
   
website design: NKD | email: info@NKD.org.uk | site: www.NKD.org.uk